Area of research
Health, Toxicology and Mutagenesis · Biotechnology
Research interest
Research interests include Effects and risks of endocrine disrupting chemicals, Toxic Organic Pollutants Impact, Cancer Research and Treatments, and Pharmaceutical and Antibiotic Environmental Impacts.
p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy
KIF18A induces the EMT process of hepatoma cells through the 5-LOX-dependent arachidonic acid pathway
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial
Traditional Chinese Medicine for the Treatment of Acute Intracerebral Haemorrhage: A Multicentre, Randomised, Placebo-Controlled, Double-Blind, Clinical Trial
Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease
Identification of Recurrence-Related mRNAs and Noncoding RNAs in Hepatocellular Carcinoma Following Liver Transplantation
Thermal preconditioning can reduce the incidence of intraoperatively acquired pressure injuries
Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression
Study of the Repellent Activity of 60 Essential Oils and Their Main Constituents against Aedes albopictus, and Nano-Formulation Development
Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
Morphological Characteristics of Posterior Wall Fragments Associated with Acetabular Both-column Fracture
High Expression of IL-4R Enhances Proliferation and Invasion of Hepatocellular Carcinoma Cells
Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling
CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway